��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title Onset of Efficacy of Lamotrigine as Initial Monotherapy for Newly-Diagnosed Absence Seizures

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Gregory L. Holmes, MD	No disclosure on file
Susan Kerls (GlaxoSmithKline)	No disclosure on file
	No disclosure on file
Anne E. Hammer (Glaxo Welcome)	No disclosure on file
	No disclosure on file
Alain Vuong (GlaxoSmithKline)	No disclosure on file
John A. Messenheimer, Jr., MD	Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.